A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia.
Leukemia
; 32(2): 413-418, 2018 02.
Article
in En
| MEDLINE
| ID: mdl-28607470
Full text:
1
Database:
MEDLINE
Main subject:
Leukemia, Myelomonocytic, Chronic
/
Decitabine
/
Antimetabolites, Antineoplastic
Type of study:
Clinical_trials
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Year:
2018
Type:
Article